LoRusso, P.;
Krop, I. E.;
Burris, H. A.;
Vukelja, S. J.;
Miller, K.;
Zheng, M.;
Chu, Y.;
Lu, M.;
Amler, L. C.;
Rugo, H. S.
Quantitative assessment of diagnostic markers and correlations with efficacy in two phase II studies of trastuzumab-DM1 (T-DM1) for patients (pts) with metastatic breast cancer (MBC) who had progressed on prior HER2-directed therapy
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Quantitative assessment of diagnostic markers and correlations with efficacy in two phase II studies of trastuzumab-DM1 (T-DM1) for patients (pts) with metastatic breast cancer (MBC) who had progressed on prior HER2-directed therapy
Contributor:
LoRusso, P.;
Krop, I. E.;
Burris, H. A.;
Vukelja, S. J.;
Miller, K.;
Zheng, M.;
Chu, Y.;
Lu, M.;
Amler, L. C.;
Rugo, H. S.
imprint:
American Society of Clinical Oncology (ASCO), 2010